60 participants enrolled (20 from each clinic over 12 weeks)
No, only 10 participants enrolled
4.
50% target patients (presenting to participating drug services for a new episode of OST) eligible and consented
No, only 9% of target population were eligible and consented due to low numbers presenting for OST at all clinics and high numbers excluded due to receiving buprenorphine and not attending a participating pharmacy
5.
> 95% consistency in recording of pharmacy attendance (comparing daily pharmacy dispensing records vs. patient self-login)
Yes, achieved 96%
6.
Rates of follow-up at 12 weeks (> 70%)
Yes, achieved 90% (9/10)
7.
Completion rates of economic data collection (> 70%)
